Loss of Muscle Mass Could Signal Higher Risk for Alzheimer’s Disease

A new study published in Scientific Reports suggests that sarcopenia—the age-related loss of muscle mass and strength—may be an early warning sign for Alzheimer’s disease and could predict how the disease progresses.

Researchers at Korea University Guro Hospital examined 200 participants, including healthy individuals and those at various stages of Alzheimer’s disease. They found that people with sarcopenia were nearly five times more likely to show signs of Alzheimer’s disease compared to those with normal muscle mass and strength.

“This is the first study to establish such a clear connection between muscle loss and biomarker-confirmed Alzheimer’s disease in Asian populations,” explains Dr. Sung Hoon Kang, one of the study’s lead authors. The research is particularly significant because it used advanced brain imaging to confirm the presence of amyloid-beta, a protein strongly associated with Alzheimer’s disease.

The study revealed that participants with sarcopenia not only had higher rates of Alzheimer’s disease but also showed more severe symptoms. These individuals had:

  • Smaller hippocampus volume (a brain region crucial for memory)
  • Lower scores on cognitive tests
  • More severe clinical symptoms of dementia

The connection between muscle health and brain function might seem surprising, but Dr. Kang’s team suggests several possible explanations. Muscles produce important proteins and growth factors that may help protect the brain. When muscle mass decreases, the production of these protective factors may also decline, potentially leaving the brain more vulnerable to Alzheimer’s disease.

These findings have important implications for public health. “Since sarcopenia can be improved through strength exercises and proper diet, our results suggest new possibilities for preventing or slowing the progression of Alzheimer’s disease,” notes Dr. Kyungmi Oh, another lead researcher on the study.

The research team emphasizes that while these results are promising, more studies are needed to confirm whether treating sarcopenia could actually prevent or slow Alzheimer’s disease progression. However, this study adds to growing evidence that maintaining muscle mass and strength through regular exercise and proper nutrition might be crucial for brain health, particularly as we age.

For the general public, this research underscores the importance of maintaining muscle strength throughout life, not just for physical health but potentially for cognitive health as well. Under appropriate medical supervision, regular strength training and adequate protein intake may be even more important than previously thought for healthy aging.

Reference: Kim J, Suh SI, Park YJ, Kang M, Chung SJ, Lee ES, Jung HN, Eo JS, Koh SB, Oh K, Kang SH. Sarcopenia is a predictor for Alzheimer’s continuum and related clinical outcomes. Sci Rep. 2024 Jan;14(1):21074.